Diarrhea during the Conditioning Regimen Is Correlated with the Occurrence of Severe Acute Graft-versus-Host Disease through Systemic Release of Inflammatory Cytokines

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 11, 2010, Pages 1567-1575

  Liu, Daihong ^a   Yan, Chenhua ^a   Xu, Lanping ^a   Wang, Yu ^a   Han, Wei ^a   Zhang, Xiaohui ^a   Liu, Kaiyan ^a   Huang, Xiaojun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Acute graft versus host disease; Allogeneic hematopoietic stem cell transplantation; Diarrhea related to the conditioning regimen; Interleukin 6 (IL 6); Tumor necrosis factor (TNF )

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 6; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CYTOKINE RELEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADOLESCENT; ADULT; CHILD; CYTOKINES; DIARRHEA; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77957755176     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.05.001     Document Type: Article

References (24)

1. Cooke K.R., Hill G.R., Crawford J.M., et al. Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998, 102:1882-1891.
2. Visentainer J.E., Lieber S.R., Persoli L.B., et al. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation. Exp Hematol 2003, 31:1044-1050.
3. Sakata N., Yasui M., Okamura T., et al. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donor: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant 2001, 27:1153-1161.
4. Shaiegan M., Iravani M., Babaee G.R., et al. Effect of IL-18 and sIL-2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Transplant Immunol 2006, 15:223-227.
5. Schots R., Kaufman L., Van Riet I., et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003, 17:1150-1156.
6. Tomas E.D., Storb R., Clift R.A., et al. Bone marrow transplantation. N Engl J Med 1975, 292:895.
7. Huang X.J., Jiang Q., Chen H., et al. Low-dose methotraxate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005, 36:343-348.
8. Yan C.H., Liu D.H., Xu L.P., et al. Etiology of diarrhea after allogeneic haemotopoietic stem cell transplantation: a retrospective study. Chin J Pract Intern Med 2009, 29:622-625.
9. Cox D.R. The Analysis of Binary Data 1970, Methuen, London.
10. Perkins N.J., Schisterman E.F. The Youden Index and the optimal cut-point corrected for measurement error. Biomed J 2005, 47:428-441.
11. Efron B. Logistic regression, survival analysis and the kaplan-meier curve. J Am Stat Assc 1988, 83:414-425.
12. Holler E., Kolb H.I., Hintenneier-Knabe R., et al. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant Proc 1993, 25:1234-1245.
13. Holler E., Kolb H.J., Moller A., et al. Increased serum levels of tumor necrosis factor a preceede major complications of bone marrow transplantation. Blood 1990, 75:1011-1016.
14. Abdallah A.N., Boiron J.M., Cassaigne A.A., et al. Plasma cytokines in graft vs host disease and complications following bone marrow transplantation. Hematol Cell Ther 1997, 39:27-32.
15. Reinecker H.C., Steffen M., Witthoeft T., et al. Enhanced secretion of tumor necrosis factor-alpha, IL-6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993, 94:174-181.
16. Leon A.J., Gomez E., Garrote J.A., et al. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm 2009, 2009:580450.
17. Logan R.M., Stringer A.M., Bowen J.M., et al. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 2007, 33:448-460.
18. Lima V., Brito G.A., Cunha F.Q., et al. Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. Eur J Oral Sci 2005, 113:210-217.
19. Goldberg F., Facobsobn D.A., Zaburak M.L., et al. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease. Biol Blood Marrow Transplant 2005, 11:101-107.
20. Beelen D.W., Haralambie E., Brandt H., et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduce the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood 1992, 80:2668-2676.
21. Nestel F.P., Price K.R., Seemayer T.A., et al. Marcrophage priming and lipoplysaccharide- triggered release of tumour necrosis factor α during graft-versus-host disease. J Exp Med 1992, 175:405-413.
22. Cooke K.R., Gerbitz A., Grawford J.M., et al. LPS antagonism reduces graft-versus-host disease and preserve graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001, 107:1581-1589.
23. Liu Z.G., Yuan X.P., Luo Y.W., et al. Evaluation the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. Cytokine 2009, 45:141-147.
24. Can M., Gul S., Bektas S., et al. Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury. Acta Anaesthesiol Scand 2009, 53:1068-1072.